NEHEN March Meeting: Financing Trends for Life Sciences and Healthcare Innovation
A Comprehensive Perspective of Today’s Financial Markets for Life Science Companies
Foley Hoag LLP
155 Seaport Boulevard
Boston, MA 02210-2600
Presented By New England Healthcare Executives
Join us for a panel discussion of the past, present and future trends in life science financial markets. Healthcare companies have livened the public stock markets with significant gains over the last five years including a 150% increase in the NYSE ARCA Biotech Index (BTK) as of January 22nd and over 160 IPOs and significant M&A activity. However, the BTK has dropped over 25% in the last six months creating new uncertainties driven by drug pricing, data, expectations, execution and many other factors. Our panel includes experts from across the industry that are on the front lines. Let’s hear what they have so say about the future moving forward.
Program Moderator: Douglas MacDougall, President, MacDougall Biomedical Communications
- Noubar Afeyan, Ph.D., Senior Managing Partner and CEO, Flagship Partners, Boston
- Adam Feuerstein, Senior Columnist, TheStreet
- Peter Kolchinski, Ph.D., Managing Partner, RA Capital Management, LLC
- Peter Riekes, Vice Chairman, Investment Banking Division, Stifel, Nicolaus & Company, Inc.